ACRUX LIMITED

6.67%

1.4¢

Market Cap $4.106M

Healthcare Biotechnology

Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is... Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is engaged in developing and commercializing a pipeline of topically applied pharmaceutical products. Its products include Lidocaine and Prilocaine Cream, USP 2.5%/2.5%, Lenzetto, Evamist, Dapsone Gel, 5% and Testosterone Topical Solution, 30 mg / 1.5 ml. Lidocaine and Prilocaine Cream USP (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on normal intact skin for local analgesia and genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia. Lenzetto (estradiol 1.53 mg/spray, transdermal spray, solution) is an estradiol spray for women which is used to treat moderate to severe hot flushes commonly associated with menopause. Testosterone Topical Solution is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.More

Neurizon's (ASX:NUZ) NUZ-001 OLE Study Demonstrates Long-Term Safety and Efficacy Signals

Latest Threads

Tag

Subject

ACR

Ann: Divestment of Prilocaine 2.5% and Lidocaine 2.5%, Cream

30/12/25

1.5K

30/12/25

Last post mwilson25

1.5K

ACR

Ann: AGM Presentation and Address

12/12/25

1.2K

12/12/25

Last post Phibonarchery

1.2K

ACR

Ann: Appendix 3Y Warmbrunn

03/12/25

121

03/12/25

Last post

ASX News

121

ACR

Ann: Notification regarding unquoted securities - ACR

03/12/25

117

03/12/25

Last post

ASX News

117

ACR

Ann: Notification of cessation of securities - ACR

03/12/25

118

03/12/25

Last post

ASX News

118

ACR

Ann: Appendix 3Y Brooke

03/12/25

Last post

ASX News

ACR

Ann: Appendix 3Y Oldham

03/12/25

102

03/12/25

Last post

ASX News

102

ACR

Ann: Appendix 3Y Brumley

03/12/25

Last post

ASX News

See All Discussions

Timeline

Divestment of Prilocaine 2.5% and Lidocaine 2.5%, Cream
12 Dec 09:26	Share

Appendix 3Y Warmbrunn
03 Dec 11:11	Share

Notification regarding unquoted securities - ACR
03 Dec 11:11	Share

Notification of cessation of securities - ACR
03 Dec 10:09	Share

Appendix 3Y Brooke
03 Dec 09:47	Share

Appendix 3Y Oldham
03 Dec 09:46	Share

Appendix 3Y Brumley
03 Dec 09:45	Share

Appendix 3Y Dobinson
03 Dec 09:42	Share

Notification regarding unquoted securities - ACR
03 Dec 09:41	Share

Results of Annual General Meeting
25 Nov 11:37	Share

AGM Presentation and Address
25 Nov 08:37	Share

Notification of cessation of securities - ACR
24 Nov 08:38	Share

Appendix 3Y Oldham
24 Nov 08:37	Share

Appendix 3Y Brumley
24 Nov 08:36	Share

Application for quotation of securities - ACR
24 Nov 08:36	Share

Acrux receives $0.4m advance on FY26 R&D Tax Incentive
13 Nov 08:21	Share

Updated September Quarter Activities Statement and App4C
04 Nov 09:20	Share

Quarterly Activities/Appendix 4C Cash Flow Report
31 Oct 11:51	Share

Notice of Annual General Meeting/Proxy Form
24 Oct 08:31	Share

Notification of AGM date and nomination of directors
30 Sep 15:30	Share

Notification regarding unquoted securities - ACR
22 Sep 09:58	Share

Received $3.04m RDTI rebate for FY25
04 Sep 08:24	Share

Appendix 4G and Corporate Governance Statement FY25
29 Aug 08:58	Share

Appendix 4E and Full Year Statutory Accounts FY25
29 Aug 08:57	Share

Licensing partnership in Saudi Arabia for Dapsone 5%, Gel
31 Jul 09:01	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Jul 09:03	Share

Receipt of second advance for FY25 R&D Tax Incentive
03 Jul 09:29	Share

Notification of cessation of securities - ACR
03 Jul 09:24	Share

Application for quotation of securities - ACR
03 Jul 09:23	Share

Change in substantial holding
30 Jun 14:58	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.4¢		Change -0.001(6.67%)		Mkt cap ! $4.106M

Open	High	Low	Volume
1.4¢	1.4¢	1.4¢	845.4K

Buyers (Bids)

Vol.	Price($)
2101482	1.4¢

Sellers (Offers)

Price($)	Vol.
1.5¢	278000

Last trade - 16.10pm 13/01/2026 (20 minute delay)

ACR (ASX) Chart

ACRUX LIMITED

Latest Threads

Timeline

Featured News

Latest Articles

Acrux scores fourth FDA approval, Nitroglycerin Ointment moving into commercialisation

Acrux Ltd has achieved the fourth approval from the US FDA, with its Nitroglycerin Ointment 0.4%, ready for commercialisation

US FDA approves review of Acrux (ASX:ACR) nitroglycerin ointment

Acrux (ASX:ACR) has received approval from the US FDA to review a generic version of its nitroglycerin ointment at 0.4 per cent concentration.

Acrux (ASX:ACR) announces buyout of future Lenzetto royalties

Pharmaceutical company Acrux (ACR) has reached an agreement for the EUR 4.10 million (A$6.41 million) buyout of future royalties for the company's Lenzetto product.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News